Latest news
FPH wins patent opposition case against rival Resmed - National Business ReviewNational Business Review · Fri, 07 Aug 2026 04:58:50 GMTResMed beats on earnings and ups dividend, yet shares plummet - Market IndexMarket Index · Fri, 07 Aug 2026 04:46:29 GMTDoes Higher EPS Guidance In Sleep And Breathing Health Shift The Bull Case For ResMed (RMD)? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 10:29:00 GMTWhat Keeps What Is Shifting the Case for ResMed (ASX:RMD) on Watch This Reporting Season? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 04:11:00 GMTHealthscope’s not-for-profit plan delays lender payout for two years - AFRAFR · Sun, 02 Aug 2026 22:19:00 GMTResmed's Q4 Earnings on Deck: What's in Store for the Stock? - TradingViewTradingView · Fri, 31 Jul 2026 13:32:00 GMTResMed (RMD) Could Be 14% Undervalued On Its Sleep Health Growth Story - SahmSahm · Wed, 29 Jul 2026 07:00:00 GMTResMed shares are at their cheapest valuation in a decade. Time to pounce? - The Motley Fool AustraliaThe Motley Fool Australia · Sun, 26 Jul 2026 20:12:59 GMT